This site is intended for healthcare professionals only
LoginRegister
Glenmark Pharma appoints Anurag Mantri as PresidentGlenmark Pharma names Anurag Mantri as President
Aurobindo Pharma Slapped Rs 77.6 Crore GST Demand, Penalty in IGST Refund DisputeAurobindo Pharma arm gets European Commission authorization to market Dyrupeg in EU
GlaxoSmithKline Pharma Upendra Singh resigns as Commercial Head - General MedicinesGlaxoSmithKline Pharma Upendra Singh resigns as Commercial Head - General Medicines
Rick Suarez Named Head of AstraZenecas US Biopharma Business Amid USD 50 Billion Expansion PlanAstraZeneca Pharma India gets CDSCO nod to import, distribute lung cancer drug Osimertinib
Sanofi Consumer Healthcare India: CFO Maithilee Mistry, Head of Commercial Operations Rupendra Sachdev to step downSanofi Consumer Healthcare India: CFO Maithilee Mistry, Head of Commercial Operations Rupendra...
CDSCO Declares 74 Medicines, APIs and Devices Samples Not of Standard Quality in December56 Formulations declared Not of standard quality as per data provided by states: CDSCO Drug Alert
Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE MarkRisdiplam Price Disparity in India vs China, Pakistan: SC Issues Notice to Roche
CDSCO Expert Panel Backs Akums Faropenem Dispersible Tablets, Grants CT, BE WaiversSubmit in vitro study data and justify dose: CDSCO Panel Tells Akums Drugs on Veterinary Antibiotic...
Novartis AG to Exit India Arm in Rs 1,446 Cr Deal, ChrysCapital-Led Consortium Buys 70.68% StakeNovartis Healthcare Gets CDSCO Panel Nod To study Anti-cancer Drug Asciminib
Torrent Pharma Appoints Former Cipla Global CTO Geena Malhotra as Chief Technology OfficerTorrent Pharmaceutical gets CDSCO Panel nod to conduct bioequivalence study of Prucalopride oral...
NPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, GemcitabineNPPA Revises Ceiling Price of 6 Formulations, details
CDSCO to Reject Long-Pending SUGAM Applications After 30 Days for Non-Response to QueriesCDSCO Directs Drug Controllers To Tighten Watch On Banned Chloramphenicol, Nitrofurans Formulations
X